Syndax Pharmaceuticals SNDX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's enterprise value?
- Syndax Pharmaceuticals (SNDX) reported enterprise value of $2.28B in Q1 2026.
- How has Syndax Pharmaceuticals's enterprise value changed year-over-year?
- Syndax Pharmaceuticals's enterprise value increased by 84.0% year-over-year, from $1.24B to $2.28B.
- What is the long-term trend for Syndax Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's enterprise value has grown at a 13.5% compound annual growth rate (CAGR), from $1.09B to $2.04B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.